John R. Schwab - Dec 2, 2022 Form 4 Insider Report for Vertex, Inc. (VERX)

Signature
/s/ Lisa Coleman, Attorney-in-Fact
Stock symbol
VERX
Transactions as of
Dec 2, 2022
Transactions value $
-$294,304
Form type
4
Date filed
12/6/2022, 03:31 PM
Previous filing
Nov 12, 2021
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERX Class A Common Stock Options Exercise $78.3K +16.7K +298.66% $4.70 22.2K Dec 2, 2022 Direct
transaction VERX Class A Common Stock Sale -$280K -16.7K -74.92% $16.79 5.58K Dec 2, 2022 Direct F1
transaction VERX Class A Common Stock Options Exercise $4.23K +899 +16.11% $4.70 6.48K Dec 5, 2022 Direct
transaction VERX Class A Common Stock Sale -$14.6K -899 -13.88% $16.28 5.58K Dec 5, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERX Stock Option Options Exercise -$78.3K -16.7K -3.36% $4.70 480K Dec 2, 2022 Class A Common Stock 16.7K $4.70 Direct F3
transaction VERX Stock Option Options Exercise -$4.23K -899 -0.19% $4.70 479K Dec 5, 2022 Class A Common Stock 899 $4.70 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.75 to $16.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.26 to $16.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 This option became exercisable with respect to 50% of the shares on February 5, 2022, and will vest with respect to the remaining shares on February 5, 2025.